Vossloh Upgraded to Buy on Strong Growth Prospects and Attractive Valuation
Jefferies analyst Fabian Piasta upgraded the rating on Vossloh (0N2Z – Research Report) to a Buy today, setting a price target of €57.00.
2 Growth Stocks to Buy and Hold Forever
Recent declines in these top Canadian growth stocks could be an opportunity for long-term investors to buy them at a ...
Buy Rating Reaffirmed for Prime Medicine on Strong Cash Position and Promising Technology Platforms
Prime Medicine, Inc. (PRME – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...
What’s Going on With Kinaxis Stock?
Kinaxis stock looks like a solid long-term option and may already have some growth momentum that investors need to watch. The post What’s Going on With Kinaxis Stock? appeared first on The Motley Fool ...